Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

Part of paid clinical trials in Duarte, California.

Sponsor
City of Hope Medical Center
Study ID
NCT05519878
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Best Practice — OTHER
    Undergo routine treatment and usual follow up care
  • Bright White Light Therapy — DEVICE
    Undergo bright white therapy
  • Occupational Therapy — BEHAVIORAL
    Undergo occupational therapy
  • Questionnaire Administration — OTHER
    Complete questionnaires

Study Details

This clinical trial evaluates light therapy and occupational therapy in improving cancer related fatigue (CRF) patients with genitourinary cancers. Light therapy is a non-pharmacological and evidence-based intervention for managing fatigue in cancer patients. The use of light therapy can provide a low burden, inexpensive, and easy to disseminate intervention approach that can potentially have a larger impact on CRF. In addition, occupational therapy is a standard, but often underutilized, component of the multi-disciplinary approach to cancer care. Using the combination of light therapy and occupational therapy may be effective in CRF management.

Key Dates

Start date
Nov 29, 2022
Status verified
Dec 2025
Primary completion
May 25, 2027
Completion
May 25, 2027

Study Design

Enrollment
224 participants (estimated)
Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Arm I (BWL)
    Patients self-administer 30 minutes of light delivered via light glasses every morning for 3 months. Patients attend 6 follow up sessions to address any questions regarding the wearable light therapy glasses.
  • Experimental: Arm II (OT)
    Patients undergo 6 occupational therapist-led sessions over 60 minutes each.
  • Experimental: Arm III (OT, BWL)
    Patients self-administer 30 minutes of light delivered via light glasses every morning for 3 months. Patients attend 6 follow up sessions to address any questions regarding the wearable light therapy glasses and to complete the occupational therapist-led session over 60 minutes.
  • Active Comparator: Arm IV (Control)
    Patients undergo routine treatment and usual follow up care with their medical oncologist.

Primary Outcome Measure

Functional Assessment of Cancer Therapy - (FACIT) [ Time Frame: At baseline ]

Locations (1)

FacilityCityStateZIPSite coordinators
City of Hope Medical CenterDuarteCalifornia91010
William Dale
[email protected]
626-256-4673
William Dale (PRINCIPAL_INVESTIGATOR)

Find similar trials in Duarte, CA

By condition
Prostate cancer
By specialty
OncologyProstate oncologyMen's healthUrology
By research site
City of Hope Medical Center· Duarte, CA

Related Studies